Conference Coverage

ALN
Addressing Clinical Challenges in the Management of SLE With Dr Petri
April 18, 2021
The early and accurate diagnosis is essential in the management of systemic lupus erythematosus, according to Michelle Petri, MD, who spoke at the virtual Interdisciplinary Autoimmune Summit on April 17, 2021.
IMID-JAK Pearls from Dr Ruth Ann Vleugels
April 18, 2021
At the Interdisciplinary Autoimmune Summit, Ruth Ann Vleugels, MD, MPH, MBA, presented “Strategies for Improving IMID Outcomes: The Potential of JAK Inhibitors,” sharing a number of pearls when it comes to utilizing JAK inhibitors for the treatment of immune-mediated inflammatory diseases.
ALN
Jason Schairer, MD, on Dermatologic Manifestations in IBD
March 02, 2021
In this Q&A, Dr Schairer answers our questions about the presentation, diagnosis, and treatment of dermatological conditions among patients with inflammatory bowel disease.
Rheumatology Consultant
A Preview of the ACR Guideline for the Management of Rheumatoid Arthritis
December 07, 2020
In this video, Liana Fraenkel, MD, MPH, previews the recommendations that are included in the ACR guideline for the management of rheumatoid arthritis.
Rheumatology Consultant
How Common Is Diagnostic Delay in PsA?
November 13, 2020
While early diagnosis of psoriatic arthritis is key, a new study that was released during ACR Convergence shows that there is often a delay in diagnosis. Find out which patients are at the highest risk for delayed diagnosis.
Rheumatology Consultant
Survey Highlights Aspects of RA Management That Need Improvement
November 10, 2020
Patients with rheumatoid arthritis recently completed a survey about their experiences and satisfaction with their rheumatologist. The survey’s results were released during ACR Convergence.
Gastro Learning Network
Biomarkers for the Optimization of IBD: Finding Precision
October 27, 2020

According to Dermot McGovern, MD, gastroenterologists are already practicing precision medicine in caring for patients with inflammatory bowel disease. Read on for more of his presentation at the Advances in Inflammatory Bowel Diseases virtual regional meeting April 16.

Gastro Learning Network
IL-12/23 Inhibitors Demonstrate Efficacy in IBD With Excellence Safety Profile
October 27, 2020

At the Advances in Inflammatory Bowel Diseases virtual regional meeting April 16, Uma Mahadevan, MD, highlighted the safety and efficacy of ustekinumab for IBD care, and noted that new interleukin inhibitors are soon to come.

Gastro Learning Network
Setting the Stage: The Latest Treatment Algorithms in IBD
October 27, 2020

William Sandborn, MD, from the University of California San Diego, the use of algorithms based on the results of meta-analyses of trials to position first- and second-line therapeutic agents to achieve the best outcomes in caring for patients with inflammatory bowel disease.

Gastro Learning Network
Uma Mahadevan, MD, on the PIANO Study of Pregnancy and IBD
October 27, 2020

PIANO is a landmark study and registry developed to follow the effects of treatment for inflammatory bowel disease among women during pregnancy and their children following birth. Principal investigator Uma Mahadevan, MD, from the University of California San Francisco, answered some questions…

Back to Top